Python hunters have nothing to be afraid of when it comes to venom and pythons. They are not venomous. But they have very sharp teeth.

Biobeat Technologies has raised $50 million in a series B round to help boost the commercialization of its blood pressure sensor. The medtech, which touts itself as the developer of the first ...

TOPEKA, Kan. (WIBW) - The Topeka Police Dept. is using Law Enforcement Appreciation Day to invite you to support the community. They’re teaming up with Kansas Concerns of Police Survivors for the Blue ...

TOPEKA, Kan. (WIBW) - The Topeka Police Department (TPD) is hosting a Blue Blood Drive on Wednesday, Jan. 7. TPD is partnering with Kansas Concerns of Police Survivors (KS C.O.P.S.) and the American ...

One of the things I need to do when I’m about to go out of the office is to set up my automatic replies in Microsoft Outlook. It’s usually the last thing I do before I sign off and it can be really ...

Hims & Hers Health, Inc. (NYSE: HIMS) on Wednesday agreed to acquire YourBio Health, Inc., a Boston-based provider of capillary whole blood sampling technology. YourBio Health develops technologies ...

Last month, FBI Director Kash Patel announced that the Secret Service discovered a “suspicious” hunting stand near Palm Beach International Airport with a direct sight line to where President Donald ...

There’s no need for an expensive, professionally installed home security system for a little peace of mind. You can keep tabs on your home when you’re away, check in on your kids or pets, and ...

A blood centrifuge rotates between 3,000 and 5,000 times per minute, causing blood to separate into three distinct layers: dark and dense red blood cells at the bottom, a very thin layer of white ...

Heavy D sets up a giant wood-fired cauldron hot tub deep in snowy mountains. How a DNA test solved a medical mystery – and revealed a doctor’s decades of deception Tips for Trump on Russia (from an ex ...

Novo Nordisk NOVO.B-4.02%decrease; red down pointing triangle said it would take over a drug under development to treat rare blood and kidney disorders from Nasdaq-listed biopharmaceutical firm Omeros ...